Avastin Related Clinical Trials
MAAM Study: Avastin and Macugen Versus Avastin Versus Macugen [Recruiting]
A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) [Active, not recruiting]
Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma [Active, not recruiting]
A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma [Completed]
A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer [Terminated]
Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy [Active, not recruiting]
Evaluation of Contrast-Enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases [Recruiting]
A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer. [Active, not recruiting]
Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast Cancer [Recruiting]
A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. [Active, not recruiting]
Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization [Recruiting]
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma [Suspended]
Combination Therapy for Age-Related Macular Degeneration. [Recruiting]
Systemic Avastin Therapy in Age-Related Macular Degeneration [Recruiting]
An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study [Completed]
The Avastin vs Visudyne for Neovascular AMD Study [Withdrawn]
Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. [Active, not recruiting]
A Study of Avastin (Bevacizumab) in Women With HER2 Negative Metastatic Breast Cancer [Active, not recruiting]
A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma. [Recruiting]
Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions? [Recruiting]
Avastin/Radiation (XRT)/Temozolomide Followed by Avastin/Temozolomide/Topotecan for Glioblastoma [Recruiting]
Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299) [Recruiting]
Taxotere Plus Bevacizumab (AVF3110) [Recruiting]
Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-Small Cell Cell Lung Cancer [Recruiting]
Carboplatin Taxol Avastin in Ovarian Cancer (OVCA) [Recruiting]
Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer [Recruiting]
Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma [Completed]
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract. [Recruiting]
Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Patients With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy [Recruiting]
Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis [Recruiting]
Bevacizumab and AZD2171 in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma [Recruiting]
Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) [Recruiting]
Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma [Recruiting]
Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer [Recruiting]
Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer [Recruiting]
Bevacizumab and Irinotecan in Treating Patients With Recurrent High-Grade Malignant Glioma That Progressed on Bevacizumab Alone [Recruiting]
LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma [Recruiting]
Intravitreal Bevacizumab for Retinal Disorders [Recruiting]
A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer. [Recruiting]
A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) in Elderly Patients With Metastatic Colorectal Cancer. [Recruiting]
Intravitreal Avastin Versus Intravitreal Avastin and Triamcinolone in Central Retinal Vein Occlusion(CRVO) [Recruiting]
Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer [Recruiting]
Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM) [Recruiting]
A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer. [Recruiting]
Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer. [Recruiting]
Avastin for PDR (Proliferative Diabetic Retinopathy) [Recruiting]
Bevacizumab(Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma [Recruiting]
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma
Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma [Recruiting]
Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma [Recruiting]
Trial of Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer in Previously Treated Patients [Suspended]
Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma [Recruiting]
Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC) [Recruiting]
Avastin and Taxotere for Esophagogastric Cancer [Active, not recruiting]
Bevacizumab in Advanced Hepatocellular Carcinoma [Recruiting]
Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors [Recruiting]
Radiosensitization of AVASTIN� (Bevacizumab) With Stereotactic Body Radiotherapy for Colorectal Liver Metastasis [Recruiting]
Neuradiab� Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme [Not yet recruiting]
Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma [Recruiting]
Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma [Recruiting]
HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver [Recruiting]
Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer [Recruiting]
AMG 102 and Avastin for Recurrent Malignant Glioma [Recruiting]
Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD) [Recruiting]
Intraocular Bevacizumab Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema [Recruiting]
Bevacizumab and Paclitaxel or Bevacizumab, Cyclophosphamide, and Capecitabine as First-Line Therapy in Treating Women With Locally Advanced, Recurrent, or Metastatic Breast Cancer [Recruiting]
Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery [Recruiting]
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO) [Recruiting]
Prospective Randomized Trial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD) [Recruiting]
A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer [Recruiting]
Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM) [Recruiting]
Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated [Recruiting]
Intraarterial Cerebral Infusion of Avastin for Vestibular Schwannoma (Acoustic Neuroma) [Recruiting]
Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer [Recruiting]
Avastin in Combo w XRT & Temozolomide , Followed by Avastin, Temozolomide & Irinotecan for GBM & Gliosarcomas [Recruiting]
Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma [Recruiting]
Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma [Recruiting]
Avastin in Combo w Temo for Unresectable or Multifocal GBMs and Gliosarcomas [Recruiting]
Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer [Recruiting]
Phase II Pilot Study of Visudyne® Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab. [Not yet recruiting]
Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin [Recruiting]
Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC [Recruiting]
Ph II Avastin + Bortezomib for Pts w Recurrent Malignant Glioma [Recruiting]
Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix [Recruiting]
Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC [Recruiting]
Avastin, Docetaxel and Androgen Deprivation Followed by Continued Avastin and Androgen Deprivation for Men With a Rising PSA After Local Therapy [Recruiting]
Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction [Recruiting]
Study Comparing Bevacizumab + Temsirolimus Vs Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects [Recruiting]
Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery [Recruiting]
Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme [Recruiting]
Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer [Recruiting]
Q3week Carboplatin With Weekly Abraxaneä And Avastin + Subsequent Dose-Dense Ac With Avastin As Neoadjuvant Therapy In Resectable And Unresectable (Stage Iia-Iiib) Her2-Negative Breast Cancer [Recruiting]
Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab in Adult Patients With Kidney Cancer [Recruiting]
Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With MPM [Recruiting]
Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy [Recruiting]
A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain [Recruiting]
Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer [Recruiting]
Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma [Recruiting]
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma [Recruiting]
Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma [Recruiting]
Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment [Recruiting]
|
